PT  - JOURNAL ARTICLE
AU  - Chan, Emily Ying Yang
AU  - Shahzada, Tayyab Salim
AU  - Sham, Tiffany Sze Tung
AU  - Dubois, Caroline
AU  - Huang, Zhe
AU  - Liu, Sida
AU  - Ying-en Ho, Janice
AU  - KC Hung, Kevin
AU  - On, Kwok Kin
AU  - Kayano, Ryoma
AU  - Shaw, Rajib
TI  - Non-pharmaceutical behavioural measures for droplet-borne biological hazards prevention: Health-EDRM for COVID-19 (SARS-CoV-2) Pandemic
AID  - 10.1101/2020.05.29.20116475
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.29.20116475
4099  - http://medrxiv.org/content/early/2020/05/29/2020.05.29.20116475.short
4100  - http://medrxiv.org/content/early/2020/05/29/2020.05.29.20116475.full
AB  - Introduction Non-pharmaceutical interventions to facilitate response to the COVID-19 pandemic, a disease caused by novel coronavirus SARS-CoV-2, are urgently needed. Using the WHO health emergency and disaster risk management (health-EDRM) framework, behavioural measures for droplet-borne communicable disease, with their enabling and limiting factors at various implementation levels were evaluated.Sources of data Keyword search was conducted in PubMed, Google Scholar, Embase, Medline, Science Direct, WHO and CDC online publication database. Using OCEBM as review criteria, 105 English-language articles, with ten bottom-up, non-pharmaceutical prevention measures, published between January 2000 and May 2020 were identified and examined.Areas of Agreement Evidence-guided behavioural measures against COVID-19 transmission for global at-risk communities are identified.Area of Concern Strong evidence-based systematic behavioural studies for COVID-19 prevention are lacking.Growing points Very limited research publications are available for non-pharmaceutical interventions to facilitate pandemic response.Areas timely for research Research with strong implementation feasibility that targets resource-poor settings with low baseline Health-EDRM capacity is urgently need.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThere is no external funding for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval is exempted as no new data were collected or used in this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData sharing is not applicable to this article as no new data were created or analyzed in this study.